ARCA:XBI

SPDR Biotech ETF

$ 81.88 0.51 ( +0.63%) 04:00 PM EST
PE Ratio:
25.79
PB Ratio:
3.89
Volume:
9.25M
Dividend Yield %:
0.22
Last Holding update 2025-02-27 140 Stocks (8 new)
Value $6.37 Bil Turnover 8 %
Top Holdings: NBIX(2.56%) ABBV(2.45%) GILD(2.40%) BMRN(2.39%) UTHR(2.34%)
Portfolio Report
Registrant: SPDR SERIES TRUST
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

SPDR Biotech ETF Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

SPDR Biotech ETF Key Statistics

Name Value
Day's Open ($) 80.99
Day's Range ($) 80.41 - 82.36
Day's Volume 9,251,461
52-Week Range ($) 66.66 - 105.47
Beta 0.94
3-Year Sharpe Ratio -0.14
3-Year Sortino Ratio -0.2
Volatility 21.07
14-Day RSI 55.24
14-Day ATR ($) 2.921766
20-Day SMA ($) 76.747

Fundamental Data

Name Value
Market Cap (Mil $) 4,970.116
Shares Outstanding (Mil) 60.7
PE Ratio 25.79
PE Ratio (10y Range) 14.4 - 25.79
PE Ratio (10y Median) 22.67
PB Ratio 3.89
PB Ratio (10y Range) 2.75 - 6.16
PB Ratio (10y Median) 4.65

Dividend Data

Name Value
Dividends per Share (TTM) ($) 0.18
Dividend Yield % 0.22
Dividend Yield % (10y Range) 0.01 - 0.81
Dividend Yield % (10y Median) 0.23
Next Dividend Payment Date
Dividend Frequency Quarterly

XBI SPDR Biotech ETF Fundamental Charts

Historical TTM Price-to-Earnings for XBI SPDR Biotech ETF

Historical TTM Price-to-Earnings without NRI for XBI SPDR Biotech ETF

Historical Price-to-Book Ratio for XBI SPDR Biotech ETF

Historical Dividend Yields for XBI SPDR Biotech ETF

SPDR Biotech ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with ARCA:XBI

No Available Data

ARCA:XBI is held by these investors

No Available Data
SPDR(R) S&P(R) Biotech ETF Top Holdings of 2024-12-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
NBIX 		Neurocrine Biosciences Inc
1,192,585
162,787.9
-25.09%
2.560
-0.60%
1.200
-28.83%
-21.44%
10,610.1
Drug Manufacturers
ABBV 		AbbVie Inc
876,908
155,826.5
-12.50%
2.450
-0.32%
0.050
+11.43%
+10.94%
342,315.0
Drug Manufacturers
GILD 		Gilead Sciences Inc
1,655,248
152,895.3
-29.57%
2.400
-0.76%
0.130
+9.78%
+13.61%
129,741.4
Drug Manufacturers
BMRN 		Biomarin Pharmaceutical Inc
2,317,876
152,354.0
+1.11%
2.390
+0.03%
1.210
-0.28%
-3.73%
12,134.2
Biotechnology
UTHR 		United Therapeutics Corp
422,192
148,966.2
-26.44%
2.340
-0.71%
0.940
-19.31%
-14.76%
13,507.8
Drug Manufacturers
BIIB 		Biogen Inc
971,104
148,501.2
-2.40%
2.330
-0.06%
0.660
-16.79%
-21.42%
17,608.2
Drug Manufacturers
MRNA 		Moderna Inc
3,567,707
148,345.3
+25.16%
2.330
+0.47%
0.920
-31.68%
-33.09%
10,755.8
Biotechnology
SRPT 		Sarepta Therapeutics Inc
1,219,474
148,275.8
-21.90%
2.330
-0.56%
1.280
-47.29%
-49.95%
5,978.9
Biotechnology
AMGN 		Amgen Inc
559,276
145,769.7
-4.46%
2.290
-0.11%
0.100
+3.27%
+11.61%
155,015.9
Drug Manufacturers
INCY 		Incyte Corp
2,109,407
145,696.7
-31.11%
2.290
-0.82%
1.090
-18.03%
-12.51%
11,694.7
Biotechnology

SPDR(R) S&P(R) Biotech ETF's Historical Top Holdings Breakdowns

SPDR(R) S&P(R) Biotech ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
PCVX 		Vaxcyte Inc2024-12-31Add
+1.21%
●
80.97 ($99.04) 117.93
$34.77
-64.89%
Add 126.49%
1,679,402
937,927
NTRA 		Natera Inc2024-12-31Reduce
-1.03%
●
117.67 ($145.95) 174
$154.89
6.13%
Reduce -40.53%
914,978
-623,503
INCY 		Incyte Corp2024-12-31Reduce
-0.82%
●
65.07 ($71.31) 83.38
$60.43
-15.26%
Reduce -31.11%
2,109,407
-952,752
GILD 		Gilead Sciences Inc2024-12-31Reduce
-0.76%
●
84.17 ($90.13) 97.9
$104.21
15.62%
Reduce -29.57%
1,655,248
-695,069
UTHR 		United Therapeutics Corp2024-12-31Reduce
-0.71%
●
348.65 ($367.72) 410
$300.76
-18.21%
Reduce -26.44%
422,192
-151,781
SMMT 		Summit Therapeutics Inc2024-12-31Add
+0.65%
●
16.98 ($19.37) 23.46
$23.62
21.94%
Add 185.17%
3,550,437
2,305,403
NBIX 		Neurocrine Biosciences Inc2024-12-31Reduce
-0.60%
●
111.62 ($123.84) 139.44
$107.24
-13.40%
Reduce -25.09%
1,192,585
-399,457
SRPT 		Sarepta Therapeutics Inc2024-12-31Reduce
-0.56%
●
104.54 ($122.56) 137.94
$60.85
-50.35%
Reduce -21.9%
1,219,474
-341,931
INSM 		Insmed Inc2024-12-31Reduce
-0.52%
●
66.29 ($72.01) 76.65
$71.40
-0.85%
Reduce -20.95%
2,060,782
-546,187
KRYS 		Krystal Biotech Inc2024-12-31Reduce
-0.51%
●
156.64 ($177.33) 199.61
$170.57
-3.81%
Reduce -41.2%
309,847
-217,075

SPDR(R) S&P(R) Biotech ETF Total Holding History ($B)

To

SPDR(R) S&P(R) Biotech ETF's Asset Allocation

To

SPDR(R) S&P(R) Biotech ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

SPDR(R) S&P(R) Biotech ETF's Hypothetical Growth since 2024-12-31

SPDR(R) S&P(R) Biotech ETF's Yearly Returns

Year Portfolio % % Excess Gain %

SPDR(R) S&P(R) Biotech ETF's Holdings Heat Map

Size field:

SPDR(R) S&P(R) Biotech ETF's Holdings Bubble Chart

SPDR(R) S&P(R) Biotech ETF News

  • 1

Discussions on SPDR Biotech ETF

User's Avatar
How would you rate this stock? XBI
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.